The Indication and Effects of the Anticoagulant Therapy on Heart Diseases : Symposium on Heart Diseases and Anticoagulants
Naoie Kumagai
Abstract
Open-access reader
Naoie Kumagai
Abstract
Open-access reader
1. The anticoagulant therapy has been administered in 89 patients of various heart diseases. 2. In rheumatic valvular disease with or without emboli the anticoagulant may be said efficient to the prevention of thromboembolism from our observations. 3. In myocardial infarction our observation are not yet too few to decide the effect of anticoagulant therapy to the rate of death. At least, reinfarction and thromboembolic episodes have not seen during anticoagulant therapy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
1. The anticoagulant therapy has been administered in 89 patients of various heart diseases. 2. In rheumatic valvular disease with or without emboli the anticoagulant may be said efficient to the prevention of thromboembolism from our observations. 3. In myocardial infarction our observation are not yet too few to decide the effect of anticoagulant therapy to the rate of death. At least, reinfarction and thromboembolic episodes have not seen during anticoagulant therapy.
Key concepts: Anticoagulant therapy, Medicine, Myocardial infarction, Anticoagulant, Cardiology, Internal medicine, Intensive care medicine